BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Samonakis DN, Koulentaki M, Coucoutsi C, Augoustaki A, Baritaki C, Digenakis E, Papiamonis N, Fragaki M, Matrella E, Tzardi M, Kouroumalis EA. Clinical outcomes of compensated and decompensated cirrhosis: A long term study. World J Hepatol 2014; 6(7): 504-512 [PMID: 25068002 DOI: 10.4254/wjh.v6.i7.504]
URL: https://www.wjgnet.com/1948-5182/full/v6/i7/504.htm
Number Citing Articles
1
Zachary R. Bergman, Greg J. Beilman. The Acute Management of Surgical Disease2022; : 487 doi: 10.1007/978-3-031-07881-1_35
2
Saad Saffo, Guadalupe Garcia‐Tsao, Tamar Taddei. SGLT2 inhibitors in patients with cirrhosis and diabetes mellitus: A tertiary center cohort study and insights about a potential therapeutic target for portal hypertensionJournal of Diabetes 2021; 13(3): 265 doi: 10.1111/1753-0407.13136
3
Maaike Biewenga, Xavier P.D.M.J. Verhelst, Martine A.M.C. Baven‐Pronk, Hein Putter, Aad P. van den Berg, Karin C.M.J. van Nieuwkerk, Henk R. van Buuren, Gerd Bouma, Ynte S. de Boer, Cedric Simoen, Isabelle Colle, Jeoffrey Schouten, Filip Sermon, Christophe van Steenkiste, Hans van Vlierberghe, Adriaan J. van der Meer, Frederik Nevens, Bart van Hoek. Development and validation of a prognostic score for long‐term transplant‐free survival in autoimmune hepatitis type 1United European Gastroenterology Journal 2021; 9(6): 662 doi: 10.1002/ueg2.12112
4
Ankur Srivastava, Simcha Jong, Anna Gola, Ruth Gailer, Sarah Morgan, Karen Sennett, Sudeep Tanwar, Elena Pizzo, James O’Beirne, Emmanuel Tsochatzis, Julie Parkes, William Rosenberg. Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver diseaseBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1039-4
5
An-Hsun Chou, Ching-Chang Chen, Yu-Sheng Lin, Ming-Shyan Lin, Victor Chien-Chia Wu, Pei-Chi Ting, Shao-Wei Chen. A population-based analysis of endovascular aortic stent graft therapy in patients with liver cirrhosisJournal of Vascular Surgery 2019; 69(5): 1395 doi: 10.1016/j.jvs.2018.06.225
6
Georgios N. Kalambokis, Nikolleta Chouliara, Ilias Tsiakas, Sempastien Filippas-Ntekuan, Maria Christaki, Grigorios Despotis, Haralampos Milionis. Impact of continued alcohol use on liver-related outcomes of alcohol-associated cirrhosis: a retrospective study of 440 patientsEuropean Journal of Gastroenterology & Hepatology 2024; 36(1): 89 doi: 10.1097/MEG.0000000000002648
7
Marcelo Kugelmas, Michelle Loftus, Emily J Owen, Hani Wadei, Sammy Saab. Expert perspectives for the pharmacist on facilitating and improving the use of albumin in cirrhosisAmerican Journal of Health-System Pharmacy 2023; 80(13): 806 doi: 10.1093/ajhp/zxad070
8
Winston E. Abara, P. Spradling, Y. Zhong, A. Moorman, E. H. Teshale, L. Rupp, S. C. Gordon, M. Schmidt, J. A. Boscarino, Y. G. Daida, S. D. Holmberg. Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with CirrhosisJournal of Gastrointestinal Cancer 2020; 51(2): 461 doi: 10.1007/s12029-019-00255-4
9
Eric Lawitz, Fred Poordad, Julio A. Gutierrez, Maria Beumont, Greet Beets, Ann Vandevoorde, Pieter Van Remoortere, Donghan Luo, Leen Vijgen, Veerle Van Eygen, Mohamed Gamil. Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus‐infected patients: Long‐term follow‐up results from the open‐label, Phase II IMPACT studyHealth Science Reports 2020; 3(2) doi: 10.1002/hsr2.145
10
Tyler J. Reed, Danielle D'Ambrosio, Barbara E.C. Knollmann-Ritschel. Educational Case: Evaluating a patient with cirrhosisAcademic Pathology 2022; 9(1): 100031 doi: 10.1016/j.acpath.2022.100031
11
Elena Curakova Ristovska. Portal Hypertension - Recent Advances2021;  doi: 10.5772/intechopen.96172
12
Emma Nilsson, Harald Anderson, Konstantina Sargenti, Stefan Lindgren, Hanne Prytz. Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long‐term follow‐up study of 1317 patientsAlimentary Pharmacology & Therapeutics 2019; 49(11): 1421 doi: 10.1111/apt.15255
13
Sumeet K. Asrani, Lauren Hall, Vikrant Reddy, Gerald Ogola, Manhal Izzy. Comorbid Chronic Diseases and Survival in Compensated and Decompensated Cirrhosis: A Population-Based StudyAmerican Journal of Gastroenterology 2022; 117(12): 2009 doi: 10.14309/ajg.0000000000001909
14
Lindsay A Sobotka, Carleen Spitzer, Alice Hinton, Anthony Michaels, A James Hanje, Khalid Mumtaz, Lanla F Conteh. Management of hepatic hydrothorax and effect on length of stay, mortality, cost, and 30‐day hospital readmissionJournal of Gastroenterology and Hepatology 2020; 35(4): 641 doi: 10.1111/jgh.14842
15
Elena Curakova Ristovska, Magdalena Genadieva-Dimitrova, Beti Todorovska. Survival in Patients with Liver Cirrhosis: A Prospective StudyPRILOZI 2023; 44(3): 41 doi: 10.2478/prilozi-2023-0045
16
Lindsay A Sobotka, Khalid Mumtaz, Alice Hinton, Sean G Kelly, Lanla F Conteh, Anthony J Michaels, A. James Hanje, Michael R Wellner. Cannabis use may reduce healthcare utilization and improve hospital outcomes in patients with cirrhosisAnnals of Hepatology 2021; 23: 100280 doi: 10.1016/j.aohep.2020.10.008
17
Hong Zhao, Qi Wang, Changling Luo, Ligai Liu, Wen Xie. Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and ChallengesBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/9609731
18
Luka Vranić, Tin Nadarevic, Davor Štimac, Mirella Fraquelli, Cristina Manzotti, Giovanni Casazza, Agostino Colli. Liver and spleen stiffness as assessed by vibration controlled transient elastography for diagnosing clinically significant portal hypertension in comparison with other elastography-based techniques in adults with chronic liver diseaseCochrane Database of Systematic Reviews 2022; 2022(8) doi: 10.1002/14651858.CD015415
19
Balakrishnan Bini, B. Vijayalakshmi, K. T. Shenoy, Joseph Kurian Mukkadan. Etiological Spectrum, Epidemiological Characteristics in Compensated and Decompensated Cirrhosis at First PresentationAsian Journal of Pharmaceutical Research and Health Care 2023; 15(4): 329 doi: 10.4103/ajprhc.ajprhc_97_23
20
Konstantinos Arvanitakis, Theocharis Koufakis, Georgios Kalopitas, Stavros P. Papadakos, Kalliopi Kotsa, Georgios Germanidis. Management of type 2 diabetes in patients with compensated liver cirrhosis: Short of evidence, plenty of potentialDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2024; 18(1): 102935 doi: 10.1016/j.dsx.2023.102935
21
Elsebeth Elmstrøm Jensen, Rikke Baltzer, Susanne Helle Bjerg, Palle Bager. Supportive care in end-stage liver disease: a clinical reviewGastrointestinal Nursing 2018; 16(6): 38 doi: 10.12968/gasn.2018.16.6.38
22
Parham Safaie, Mugilan Poongkunran, Ping-Ping Kuang, Asad Javaid, Carl Jacobs, Rebecca Pohlmann, Imad Nasser, Daryl TY Lau. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinomaWorld Journal of Gastroenterology 2016; 22(12): 3404-3411 doi: 10.3748/wjg.v22.i12.3404
23
Behailu Terefe Tesfaye, Esayas Kebede Gudina, Dula Dessalegn Bosho, Teshale Ayele Mega, Chiara Lazzeri. Short-term clinical outcomes of patients admitted with chronic liver disease to selected teaching hospitals in EthiopiaPLOS ONE 2019; 14(8): e0221806 doi: 10.1371/journal.pone.0221806
24
Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani. Managing liver cirrhotic complications: Overview of esophageal and gastric varicesClinical and Molecular Hepatology 2020; 26(4): 444 doi: 10.3350/cmh.2020.0022
25
Jae Hyun Yoon, Chung Hwan Jun, Jeong Han Kim, Eileen L. Yoon, Byung Seok Kim, Jeong Eun Song, Ki Tae Suk, Moon Young Kim, Seong Hee Kang. Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of AlcoholJournal of Korean Medical Science 2021; 36(21) doi: 10.3346/jkms.2021.36.e145
26
Frank T. Spradley, Jillian A. Smith, Barbara T. Alexander, Christopher D. Anderson. Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal diseaseAmerican Journal of Physiology-Endocrinology and Metabolism 2018; 315(5): E795 doi: 10.1152/ajpendo.00394.2017
27
E. Lawitz, F. Poordad, J. A. Gutierrez, T. N. Kakuda, G. Picchio, G. Beets, A. Vandevoorde, P. Van Remoortere, B. Jacquemyn, D. Luo, S. Ouwerkerk‐Mahadevan, L. Vijgen, V. Van Eygen, M. Beumont. Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus‐infected patients with decompensated liver diseaseJournal of Viral Hepatitis 2017; 24(4): 287 doi: 10.1111/jvh.12645
28
Gennaro D’Amico, Giovanni Perricone. Prediction of Decompensation in Patients with Compensated Cirrhosis: Does Etiology Matter?Current Hepatology Reports 2019; 18(2): 144 doi: 10.1007/s11901-019-00473-1
29
Jorge Simon, Alberto Ouro, Lolia Ala-Ibanibo, Natalia Presa, Teresa Cardoso Delgado, María Luz Martínez-Chantar. Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide TurnoverInternational Journal of Molecular Sciences 2019; 21(1): 40 doi: 10.3390/ijms21010040
30
Sehrish Kamal, Muhammad Ali Khan, Ankur Seth, George Cholankeril, Deepansh Gupta, Utkarsh Singh, Faisal Kamal, Colin W Howden, Christopher Stave, Satheesh Nair, Sanjaya K Satapathy, Aijaz Ahmed. Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-AnalysisAmerican Journal of Gastroenterology 2017; 112(10): 1495 doi: 10.1038/ajg.2017.170
31
Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatmentWorld Journal of Hepatology 2022; 14(1): 1-44 doi: 10.4254/wjh.v14.i1.1
32
Jonathan N. Thomas, Joanna Roopkumar, Tushar Patel, Matias A. Avila. Machine learning analysis of volatolomic profiles in breath can identify non-invasive biomarkers of liver disease: A pilot studyPLOS ONE 2021; 16(11): e0260098 doi: 10.1371/journal.pone.0260098
33
Lindsay A Sobotka, Rohan M Modi, Akshay Vijayaraman, A James Hanje, Anthony J Michaels, Lanla F Conteh, Alice Hinton, Ashraf El-Hinnawi, Khalid Mumtaz. Paracentesis in cirrhotics is associated with increased risk of 30-day readmissionWorld Journal of Hepatology 2018; 10(6): 425-432 doi: 10.4254/wjh.v10.i6.425
34
Mai Abdel Moneim, Doaa H. Abdelaziz, Yosra Ibrahim Nagy, Amin Abdel Baki, Ahmed S. Attia, Nirmeen Sabry. Rifaximin microbial resistance and its efficacy and safety as a secondary prophylaxis of hepatic encephalopathy in patients with hepatitis C virus‐related cirrhosisInternational Journal of Clinical Practice 2021; 75(11) doi: 10.1111/ijcp.14807
35
Sachiyo Igata, Yuko Kono, Thomas Van Houten, Calvin T. Hang, Bruno R. Cotter, Monet G. Strachan, Nagisa Morikawa, Anthony N. DeMaria. Role of Quantitation of Saline Bubble Studies in Patients with Liver CirrhosisUltrasound in Medicine & Biology 2023; 49(8): 1804 doi: 10.1016/j.ultrasmedbio.2023.04.003
36
Abdolamir Allameh, Reyhaneh Niayesh-Mehr, Azadeh Aliarab, Giada Sebastiani, Kostas Pantopoulos. Oxidative Stress in Liver Pathophysiology and DiseaseAntioxidants 2023; 12(9): 1653 doi: 10.3390/antiox12091653
37
Revanth Kalluru, Sai Gadde, Rahul Chikatimalla, Thejaswi Dasaradhan, Jancy Koneti, Swathi priya Cherukuri. Cirrhotic Cardiomyopathy: The Interplay Between Liver and HeartCureus 2022;  doi: 10.7759/cureus.27969
38
Huttakan Navadurong, Kessarin Thanapirom, Salisa Wejnaruemarn, Thaninee Prasoppokakorn, Roongruedee Chaiteerakij, Piyawat Komolmit, Sombat Treeprasertsuk. Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosisWorld Journal of Gastroenterology 2023; 29(32): 4873-4882 doi: 10.3748/wjg.v29.i32.4873
39
Ramesh Kumar, Sudhir Kumar, Sabbu Surya Prakash. Compensated liver cirrhosis: Natural course and disease-modifying strategiesWorld Journal of Methodology 2023; 13(4): 179-193 doi: 10.5662/wjm.v13.i4.179
40
Suzanna Fitzpatrick, Hazel Dhates Asunio Domingo, Sarah Merrill Finke. The Care of the Decompensated Cirrhotic PatientThe Journal for Nurse Practitioners 2017; 13(4): 256 doi: 10.1016/j.nurpra.2016.11.026
41
Amoako Duah, Adwoa Agyei-Nkansah, Foster Osei-Poku, Francisca Duah, Bright Peprah Addo, Isabelle Chemin. Sociodemographic characteristics, complications requiring hospital admission and causes of in-hospital death in patients with liver cirrhosis admitted at a district hospital in GhanaPLOS ONE 2021; 16(6): e0253759 doi: 10.1371/journal.pone.0253759
42
Ya-Chun Chang, Ying-Tang Fang, Hung-Cheng Chen, Chiung-Yu Lin, Yu-Ping Chang, Yi-Hsuan Tsai, Yu-Mu Chen, Kuo-Tung Huang, Huang-Chih Chang, Chin-Chou Wang, Meng-Chih Lin, Wen-Feng Fang. The Survival of Septic Patients with Compensated Liver Cirrhosis Is Not Inferior to That of Septic Patients without Liver Cirrhosis: A Propensity Score Matching AnalysisJournal of Clinical Medicine 2022; 11(6): 1629 doi: 10.3390/jcm11061629